Recall of anemia drug follows reports of allergic reactions, deaths

02/25/2013 | New York Times (tiered subscription model), The

Affymax and Takeda Pharmaceutical have recalled Omontys, or peginesatide, following reports of serious allergic reactions and three deaths. The drug is used to treat anemia in patients undergoing kidney dialysis. Three deaths and 16 other cases of severe reactions have been reported, according to the FDA.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN